“…Reporting and details of underlying diagnoses varied across studies, and while one study compared different chemotherapy regimens in patients with neuroblastoma, 45 the remaining 16 studies included patients with a number of different hematological 41,43,48 and/or solid tumors 22,23,47,51‐54 . Chemotherapy indications included cancer therapy 21,22,41,48,50,52,54 and/or preconditioning for HSCT (approximately 63%); for the latter the majority were for malignancy, 23,41‐47,49,51,53 with a smaller proportion (<10%) for nonmalignant (eg, aplastic anemia, metabolic disorders 21,23,42,44,47,51 ) conditions (Table 1).…”